MARJO TUPPURAINEN

Yhteystiedot

Julkaisut

• Värri, Miika; Niskanen, Leo; Tuomainen, Tomi-Pekka; Honkanen, Risto; Kröger, Heikki; Tuppurainen, Marjo T. 2020. Metabolite Profiling of Osteoporosis and Atherosclerosis in Postmenopausal Women: A Cross-Sectional Study Vascular health and risk management 16: 515-524. 2020
• Osteoporoosin diagnostiikka. Tuppurainen, Marjo / Naistentaudit ja synnytykset. 2019. 2019
• Valikoivat estrogeenireseptorin muuntelijat ja selektiiviset progesteronireseptorin muuntelijat. Tuppurainen, Marjo / Lääketieteellinen farmakologia ja toksikologia. 2019. 2019
• Vaihdevuosioireiden hormonihoito. Tuppurainen, Marjo / Lääketieteellinen farmakologia ja toksikologia. 2019. 2019
• Suun kautta otettavat ehkäisyvalmisteet. Tuppurainen, Marjo / Lääketieteellinen farmakologia ja toksikologia. 2019. 2019
• Progesteronin kliininen käyttö. Tuppurainen, Marjo / Lääketieteellinen farmakologia ja toksikologia. 2019. 2019
• Progesteronijohdokset. Tuppurainen, Marjo / Lääketieteellinen farmakologia ja toksikologia. 2019. 2019
• Paikalliset ehkäisyvalmisteet. Tuppurainen, Marjo / Lääketieteellinen farmakologia ja toksikologia. 2019. 2019
• Osteoporoosin syntymekanismi. Tuppurainen, Marjo / Naistentaudit ja synnytykset. 2019. 2019
• Osteoporoosin riskiryhmät. Tuppurainen, Marjo / Naistentaudit ja synnytykset. 2019. 2019
• Osteoporoosin määritelmä ja yleisyys. Tuppurainen, Marjo / Naistentaudit ja synnytykset. 2019. 2019
• Osteoporoosin lääkehoito. Tuppurainen, Marjo / Naistentaudit ja synnytykset. 2019. 2019
• Lääkkeenä käytettävien estrogeenien farmakokinetiikka. Tuppurainen, Marjo / Lääketieteellinen farmakologia ja toksikologia. 2019. 2019
• Ehkäisytablettien hyödyt ja haitat. Tuppurainen, Marjo / Lääketieteellinen farmakologia ja toksikologia. 2019. 2019
• Luukadon lääkkeetön ehkäisy. Tuppurainen, Marjo / Naistentaudit ja synnytykset. 2019. 2019
• Laskurit murtumariskin arviointiin. Tuppurainen, Marjo / Naistentaudit ja synnytykset. 2019. 2019
• Isanejad, M; Sirola, J; Rikkonen, T; Mursu, J; Kröger, H; Qazi, SL; Tuppurainen, M; Erkkilä, AT. 2019. Higher protein intake is associated with a lower likelihood of frailty among older women, Kuopio OSTPRE-Fracture Prevention Study European journal of nutrition 2020; 59: 1181-1189. 2019
• Ihonalaiset progestiinit. Tuppurainen, Marjo / Lääketieteellinen farmakologia ja toksikologia. 2019. 2019
• Hormonit raskauden ehkäisyssä. Tuppurainen, Marjo / Lääketieteellinen farmakologia ja toksikologia. 2019. 2019
• Hormonikierukka. Tuppurainen, Marjo / Lääketieteellinen farmakologia ja toksikologia. 2019. 2019
• Hormonaalinen jälkiehkäisy. Tuppurainen, Marjo / Lääketieteellinen farmakologia ja toksikologia. 2019. 2019
• Hormonaalinen ehkäisy ja hormonihoito. Tuppurainen, Marjo / Naistentaudit ja synnytykset. 2019. 2019
• Estrogeenien synteesi ja vaikutukset. Tuppurainen, Marjo / Lääketieteellinen farmakologia ja toksikologia. 2019. 2019
• Estrogeenien kliininen käyttö. Tuppurainen, Marjo / Lääketieteellinen farmakologia ja toksikologia. 2019. 2019
• Ehkäisytablettien ja muun lääkehoidon yhteisvaikutukset. Tuppurainen, Marjo / Lääketieteellinen farmakologia ja toksikologia. 2019. 2019
• Suuronen, Juha; Sjöblom, Samu; Tuppurainen, Marjo; Honkanen, Risto; Rikkonen, Toni; Kröger, Heikki; Sirola, Joonas. 2018. Effects of ethinyl estradiol-containing oral contraception and other factors on body composition and muscle strength among young healthy females in Finland-A cross-sectional study EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY AND REPRODUCTIVE BIOLOGY 2019; 232: 75-81. 2018
• Imtiaz B, Tuppurainen M, Rikkonen T, Kivipelto M, Soininen H, Kröger H, Tolppanen A-M. 2017. Postmenopausal hormone therapy and Alzheimer disease. A prospective cohort study. NEUROLOGY 88 11: 1062-1068. 2017
• Värri M, Niskanen L, Tuomainen T, Honkanen R, Kröger H, Tuppurainen MT. 2016. Association of adipokines and estradiol with bone and carotid calcifications in postmenopausal women. Climacteric 19 2: 204-211. 2016
• Isanejad M, Sirola J, Mursu J, Kröger H, Tuppurainen M, Erkkilä AT. 2016. Association of protein intake with bone mineral density and bone mineral content among elderly women: The OSTPRE Fracture Prevention Study Journal of nutrition health and aging 2017; 21 6: 622-630. 2016
• Isanejad Masoud, Mursu Jaakko, Sirola Joonas, Kröger Heikki, Rikkonen Toni, Tuppurainen Marjo, Erkkilä Arja T. 2015. Association of protein intake with the change of lean mass among elderly women: The Osteoporosis Risk Factor and Prevention - Fracture Prevention Study (OSTPRE-FPS). Journal of Nutritional Science 4: 1-8. 2015
• Imtiaz Bushra, Tuppurainen Marjo, Tiihonen Miia, Kivipelto Miia, Soininen Hilkka, Hartikainen Sirpa, Tolppanen Anna-Maija. 2014. Oophorectomy, Hysterectomy, and Risk of Alzheimer's Disease: A Nationwide Case-Control Study. Journal of Alzheimer's Disease 42: 575-581. 2014
• Erkkilä AT, Järvinen R, Karvonen H, Keronen L, Tuppurainen MT. 2012. Validation of a semi-quantitative FFQ using food records as a reference in older women in the Kuopio Fracture Prefention Study (OSTPRE-FPS) PUBLIC HEALTH NUTRITION 15 4: 635-639. 2012
• Leminen, H; Heliövaara-Peippo, S; Halmesmäki, K; Teperi, J; Grenman, S; Kivelä, A; Tuppurainen, M; Paavonen, J; Hurskainen, R. 2012. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on premenstrual symptoms in women treated for menorrhagia: secondary analysis of a randomized controlled trial ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA 91 3: 318-325. 2012
• Rikkonen, T; Sirola, J; Salovaara, K; Tuppurainen, M; Jurvelin, JS; Honkanen, R; Kröger, H. 2012. Muscle strength and body composition are clinical indicators of osteoporosis. CALCIFIED TISSUE INTERNATIONAL 91 2: 131-138. 2012
• Silverman, SL; Chines, AA; Kendler, DL; Kung, AW; Teglbjærg, CS; Felsenberg, D; Mairon, N; Constantine, GD; Adachi, JD; Bazedoxifene Study Group; Collaborators 249; Kröger, H; Tuppurainen, M. 2012. Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study. OSTEOPOROSIS INTERNATIONAL 23 1: 351-63. 2012
• Sirola Joonas, Rikkonen Toni, Tuppurainen Marjo, Honkanen Risto, Kröger Heikki. 2012. Should risk of bone fragility restrict weight control for other health reasons in postmenopausal women? - A ten year prospective study. MATURITAS 71 2: 162-168. 2012
• Tuppurainen, M. 2012. HT and SERMs in the long-term management of osteoporosis. MINERVA GINECOLOGICA 64: 195-205. 2012
• Sirola J, Salovaara K, Rikkonen T, Kärkkäinen M, Tuppurainen M, Jurvelin JS, Honkanen R, Kröger H. 2011. Bone health-related factors and the use of bisphosphonates in community setting - 15-year follow-up study. OSTEOPOROSIS INTERNATIONAL 22: 255-264. 2011
• Ville Juhana Waris, Joonas P. Sirola, Vesa V. Kiviniemi, Marjo T. Tuppurainen, V. Pekka Waris. 2011. Mikkeli Osteoporosis Index Identifies Fracture Risk Factors and Osteoporosis and Intervention Thresholds Parallel with FRAX Journal of Osteoporosis 2011: 1-7. 2011
• Tuppurainen M, Komulainen M. 2011. Osteoporoosi. Teoksessa: Olavi Ylikorkala, Juha Tapanainen (toim.), Naistentaudit ja synnytykset, 5, uudistettu painos.Kustannus Oy Duodecim. ss. 123-133. 2011
• Saarelainen, Jarmo; Honkanen, Risto; Kröger, Heikki; Tuppurainen, Marjo; Jurvelin, Jukka; Niskanen, Leo. 2011. Body fat distribution is associated with lumbar spine bone density independently of body weight in postmenopausal women. MATURITAS 69 1: 86-90. 2011
• Saarelainen J, Kiviniemi V, Kröger H, Tuppurainen M, Niskanen L, Jurvelin J, Honkanen R. 2011. Body mass index and bone loss among postmenopausal women: the 10-year follow-up of the OSTPRE cohort JOURNAL OF BONE AND MINERAL RESEARCH 30 2: 208-216. 2011
• Järvinen R, Tuppurainen M, Erkkilä AT, Penttinen P, Kärkkäinen M, Salovaara K, Jurvelin JS, Kröger H. 2011. Associations of dietary polyunsaturated fatty acids with bone mineral density in elderly women EUROPEAN JOURNAL OF CLINICAL NUTRITION 66: 496-503. 2011
• Heliövaara-Peippo S, Oksjoki R, Halmesmäki K, Kaaja R, Teperi J, Grenman S, Kivelä A, Surcel HM, Tomas E, Tuppurainen M, Hurskainen R, Paavonen J.. 2011. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on cardiovascular disease risk factors in menorrhagia patients: A 10-year follow-up of a randomised trial MATURITAS 69: 354-358. 2011
• Erkkilä AT, Järvinen R, Karvonen H, Keronen L, Tuppurainen MT. 2011. Validation of a semi-quantitative FFQ using food records as a reference in older women in the Kuopio Fracture Prevention Study (OSTPRE-FPS). PUBLIC HEALTH NUTRITION 2011 online: 1-5. 2011
• Heliövaara-Peippo S, Halmesmäki K, Hurskainen R, Grenman S, Kivelä A, Tomas E, Tuppurainen M & Paavonen J. 2010. The effect of hysterectomy or levonorgestrel-relaeasing intrauterine system on lower urinary tract symptoms: a 10-year follof-up study of a randomised trial. BJOG: AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY 117: 602-609. 2010
• Johanna Palmrooth, Proscovia Namujju, Aline Simen-Kapeu, Vesa Kataja, Heljä-Marja Surcel, Marjo Tuppurainen, Merja Yliskoski, Kari Syrjänen & Matti Lehtinen. 2010. Natural seroconversion to high-risk human papillomaviruses (hrHPVs) is not protective against related HPV genotypes. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES 42 5: 379-384. 2010
• Kärkkäinen MK, Tuppurainen M, Salovaara K, Sandini L, Rikkonen T, Sirola J, Honkanen R, Arokoski J, Alhava E & Kröger H. 2010. Does daily vitamin D 800 IU and calcium 1000 mg supplementation decrease the risk of falling in ambulatory women aged 65-71 years? A 3-year randomized population-based trial (OSTPRE-FPS). MATURITAS 65: 359-365. 2010
• M. Kärkkäinen, M. Tuppurainen, K. Salovaara, L. Sandini, T. Rikkonen, J. Sirola, R. Honkanen, J. Jurvelin, E. Alhava & H. Kröger. 2010. Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: a 3-year randomized population-based trial (OSTPRE-FPS). OSTEOPOROSIS INTERNATIONAL 21: 2047-2055. 2010
• Rikkonen T, Salovaara K, Sirola J, Kärkkäinen M, Tuppurainen M, Jurvelin J, Honkanen R, Alhava E, Kröger H. 2010. Physical activity slows femoral bone loss but promotes wrist fractures in postmenopausal women: a 15-year follow-up of the OSTPRE study. JOURNAL OF BONE AND MINERAL RESEARCH vol 25 11: 2332-2340. 2010
• Salovaara K, Tuppurainen M, Kärkkäinen M, Rikkonen T, Sandini L, Sirola J, Honkanen R, Alhava E, Kröger H. 2010. Effect of vitamin D(3) and calcium on fracture risk in 65- to 71-year-old women: a population-based 3-year randomized, controlled trial--the OSTPRE-FPS. JOURNAL OF BONE AND MINERAL RESEARCH 25 7: 1487-1495. 2010
• Sirola J, Koistinen AK, Salovaara K, Rikkonen T, Tuppurainen M, Jurvelin JS, Honkanen R, Alhava E, Kröger H. 2010. Bone Loss Rate May Interact with Other Risk Factors for Fractures among Elderly Women: A 15-Year Population-Based Study Journal of Osteoporosis Article ID 736391: 1-10. 2010
• Sirola J, Tuppurainen M, Rikkonen T, Honkanen R, Koivumaa-Honkanen H, Kröger H. 2010. Correlates and predictors of self-rated health and ambulatory status among elderly women - Cross-sectional and 10 years population-based cohort study. MATURITAS 65 3: 244-252. 2010
• Tuppurainen M, Härmä K, Komulainen M, Kiviniemi V, Kröger H, Honkanen R, Alhava E, Jurvelin J, Saarikoski S. 2010. Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: A 5-year follow-up. MATURITAS 66 4: 423-430. 2010
• Pentti K, Tuppurainen MT, Honkanen R, Sandini L, Kröger H, Alhava E, Saarikoski S. 2009. Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study. MATURITAS 63 1: 73-78. 2009
• Salovaara K, Hietala J, Rikkonen T, Sirola J, Tuppurainen M, Kröger H. 2009. Nilkkamurtumien vaaratekijät - OSTPRE-murtumakohortin väestöpohjainen riskitekijäanalyysi 13,9 vuoden seurannassa. SUOMEN ORTOPEDIA JA TRAUMATOLOGIA 32 3: 310-313. 2009
• Sirola J, Salovaara K, Tuppurainen M, Jurvelin JS, Alhava E, Kröger H. 2009. Sister's fracture history may be associated with perimenopausal bone fragility and modifies the predictability of fracture risk. OSTEOPOROSIS INTERNATIONAL 20 4: 557-565. 2009
• Pentti K, Tuppurainen MT, Honkanen R, Sandini L, Kröger H, Alhava E, Saarikoski S. 2009. Hormone therapy protects from diabetes: the Kuopio osteoporosis risk factor and prevention study. EUROPEAN JOURNAL OF ENDOCRINOLOGY 160 6: 979-983. 2009
• Heliövaara-Peippo S, Halmesmäki K, Hurskainen R, Teperi J, Grenman S, Kivelä A, Kujansuu E, Tuppurainen M, Vuorma S, Yliskoski M, Paavonen J. 2009. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five-year randomized controlled trial. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA 88: 1389-1396. 2009
• Kärkkäinen M, Rikkonen T, Kröger H, Sirola J, Tuppurainen M, Salovaara K, Arokoski J, Jurvelin J, Honkanen R, Alhava E. 2009. Physical tests for patient selection for bone mineral density measurements in postmenopausal women. BONE 44 4: 660-665. 2009
• Backman T, Metsä-Heikkilä M, Tuppurainen M. 2008. Onko pitkäaikainen hormonaalinen ehkäisy turvallista?. DUODECIM 124 4: 445-50. 2008
• Kärkkäinen M, Rikkonen T, Kröger H, Sirola J, Tuppurainen M, Salovaara K, Arokoski J, Jurvelin J, Honkanen R, Alhava E. 2008. Association between functional capacity tests and fractures: an eight-year prospective population-based cohort study. OSTEOPOROSIS INTERNATIONAL 19: 1203-1210. 2008
• Sandini L, Pentti K, Tuppurainen M, Kröger H, Honkanen R. 2008. Agreement of self-reported estrogen use with prescription data: an analysis of women from the Kuopio osteoporosis risk factor and prevention study (OSTPRE) MENOPAUSE 15: 282-289. 2008
• Silverman SL, Cristiansen C, Genant HK, Vukicevic S, Zanchetta JR, de VILLIERS Tj, Constantine GD, Chines AA, Kröger H, Tuppurainen M. 2008. Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial. JOURNAL OF BONE AND MINERAL RESEARCH 23 12: 1923-1934. 2008
• Sirola J, Rikkonen T, Tuppurainen M, Jurvelin JS, Alhava E, Kröger H. 2008. Grip strength may facilitate fracture prediction in perimenopausal women with normal BMD: a 15-year population-based study. CALCIFIED TISSUE INTERNATIONAL 83: 93-100. 2008
• Saarelainen J, Rikkonen T, Honkanen R, Kröger H, Tuppurainen M, Niskanen L, Jurvelin JS. 2007. Is discordance in bone measurements affected by body composition or anthropometry? A comparative study between peripheral and central devices JOURNAL OF CLINICAL DENSITOMETRY 10 3: 312-318. 2007
• Sirola J, Rikkonen T, Tuppurainen M, Jurvelin JS, Kröger H, Kröger H. 2006. Association of grip strength change with menopausal bone loss and related fractures: A population-based follow-up study. CALCIFIED TISSUE INTERNATIONAL 78: 218-226. 2006
• Tuppurainen M, Kröger H, Mahonen A, Kröger H. 2006. Periytyvätkö osteoporoosi ja luunmurtumat?. DUODECIM 122: 133-134. 2006
• Sirola J, Waris V, Tuppurainen M, Kiviniemi V, Waris P. 2006. Mikkelin Osteoporoosi -indeksi (MOI) ennustaa osteoporoottisia murtumia. SUOMEN ORTOPEDIA JA TRAUMATOLOGIA 29 3: 310-312. 2006
• Sirola J, Rikkonen T, Tuppurainen M, Honkanen R, Jurvelin JS, Kröger H. 2006. Maintenance of muscle strength may counteract weight-loss-related postmenopausal bone loss - a population based approach. OSTEOPOROSIS INTERNATIONAL 17: 775-782. 2006
• Rikkonen T, Tuppurainen M, Kröger H, Jurvelin J, Honkanen R, Kröger H. 2006. Distance of walking in childhood and femoral bne density in perimenopausal women. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY 97: 509-515. 2006
• Randell KM, Honkanen RJ, Tuppurainen MT, Kröger H, Jurvelin JS, Saarikoski S, Kröger H. 2006. Fracture risk and bone density of peri- and early postmenopausal women with uterine leiomyomas MATURITAS 53 3: 333-342. 2006
• Pentti K, Honkanen R, Tuppurainen MT, Sandini L, Kröger H, Saarikoski S, Kröger H. 2006. Hormone replacement therapy and mortality in 52- to 70-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study. EUROPEAN JOURNAL OF ENDOCRINOLOGY 154: 101-107. 2006
• Komi J, Lankinen KS, DeGregorio M, Heikkinen J, Saarikoski S, Tuppurainen M, Halonen K, Lammintausta R, Väänänen K, Ylikorkala O, Erkkola R. 2006. Effects of ospemifene and raloxifene on biochemical markers of bone turnover in postmenopausal women. JOURNAL OF BONE AND MINERAL METABOLISM 24: 314-318. 2006
• Pesonen J, Sirola J, Tuppurainen M, Jurvelin J, Alhava E, Honkanen R, Kröger H, Kröger H. 2005. High bone mineral density among perimenopausal women. OSTEOPOROSIS INTERNATIONAL 16: 1899-1906. 2005
• Saarelainen J, Honkanen R, Vanninen E, Kröger H, Tuppurainen M, Niskanen L, Jurvelin JS. 2005. Cross-calibration of lunar DPX-IQ and DPX dual-energy X-ray densitometers for bone mineral measurements in women. JOURNAL OF CLINICAL DENSITOMETRY 8 3: 320-329. 2005
• Sirola J, Tuppurainen M, Honkanen R, Jurvelin JS, Kröger H, Kröger H. 2005. Associations between grip strength change and axial postmenopausal bone loss-a 10-year population-based follow-up study. OSTEOPOROSIS INTERNATIONAL 16 12: 1841-1848. 2005
• Heikkinen A-M, Niskanen LK, Salmi JA, Koulu M, Pesonen U, Uusitupa MIJ, Komulainen MH, Tuppurainen MT, Kröger H, Jurvelin J, Saarikoski S, Kröger H. 2004. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women BONE 35: 589-594. 2004
• Sirola J, Rikkonen T, Kröger H, Honkanen R, Tuppurainen M, Airaksinen O, Saarikoski S, Kröger H. 2004. Factors related to postmenopausal muscle performance: a cross-sectional population-based study. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY 93: 102-107. 2004
• Tuppurainen M, Klimscheffskij R, Venhola M, Dieben OM. 2004. The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study. CONTRACEPTION 69: 389-394. 2004
• Tuppurainen M, Komulainen M. 2004. Osteoporoosi: Ylikorkala O, Kauppila A, Naistentaudit ja synnytykset. 4. uud. p..Duodecim. 127-134. 2004
• Sirola J, Kröger H, Honkanen R, Sandini L, Tuppurainen M, Jurvelin JS, Saarikoski S. 2003. Smoking may impair the bone protective effects of nutritional calcium: a population-based approach. JOURNAL OF BONE AND MINERAL RESEARCH 18 6: 1036-1042. 2003
• Tuppurainen M. 2003. When and how should bone mineral density be measured?. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA 82: 395-397. 2003
• Sirola J, Kröger H, Sandini L, Tuppurainen M, Jurvelin JS, Saarikoski S, Honkanen R, Kröger H. 2003. Interaction of nutritional calcium and HRT in prevention of postmenopausal bone loss: a prospective study. CALCIFIED TISSUE INTERNATIONAL 72 6: 659-65. 2003
• Tuppurainen M, Saarikoski S. 2003. Estrogens and aging: Gordin A, Kaakkola S, Teräväinen H, Parkinson¿s Disease. The XIV International Congress on Parkinson's Disease.Lippincott Williams & Wilkins. Advances in Neurology. 101-106. 2003
• Sirola J, Kröger H, Honkanen R, Sandini L, Tuppurainen M, Jurvelin JS, Saarikoski S. 2003. Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss?. OSTEOPOROSIS INTERNATIONAL 14: 27-33. 2003
• Sirola J, Kröger H, Honkanen R, Jurvelin JS, Sandini L, Tuppurainen MT, Saarikoski S, Kröger H. 2003. Factors affecting bone loss around menopause in women with HRT: a prospective study. MATURITAS 45: 159-167. 2003
• Komulainen M, Tuppurainen M, Kröger H, Kröger H, Tuppurainen M. 2003. Luut murtuvat ilman estrogeenia. DUODECIM 119: 2183-2189. 2003
• Juntunen M, Niskanen L, Saarelainen J, Tuppurainen M, Saarikoski S, Honkanen R. 2003. Changes in body weight and onset of hypertension in perimenopausal women JOURNAL OF HUMAN HYPERTENSION 17: 775-779. 2003
• Niskanen L, Laitinen T, Tuppurainen M, Saarikoski S, Kröger H, Alhava E, Hartikainen J. 2002. Does postmenopausal hormone replacement therapy affect cardiac autonomic regulation in osteoporotic women?. MENOPAUSE 9: 52-57. 2002
• Valtola A, Honkanen R, Kröger H, Tuppurainen M, Saarikoski S, Alhava E. 2002. Lifestyle and other factors predict ankle fractures in perimenopausal women: A population-based prospective cohort study. BONE 30 1: 238-242. 2002
• Honkanen R, Komulainen M, Kröger H, Tuppurainen M, Alhava E, Saarikoski S. 2001. Effect of calcium on bone loss and fractures according to estrogen repletion status. Teoksessa: Burckhardt P, Dawson-Hughes B, Heaney RP (toim.), Nutritional Aspects of Osteoporosis.Academic Press. ss. 51-64. 2001
• Puntila E, Kröger H, Lakka T, Tuppurainen M, Jurvelin J, Honkanen R. 2001. Leisure-time physical activity and rate of bone loss among peri- and postmenopausal women: a longitudinal study. BONE 29 5: 442-446. 2001
• Randell KM, Honkanen RJ, Komulainen MH, Tuppurainen MT, Kröger H, Saarikoski S. 2001. Hormone replacement therapy and risk of falling in early postmenopausal women-a population-based stydy. CLINICAL ENDOCRINOLOGY 54: 769-774. 2001
• Heikkinen AM, Kröger H, Niskanen L, Komulainen MH, Ryynänen M, Parviainen MT, Tuppurainen MT, Honkanen R, Saarikoski S. 2000. Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women?. MATURITAS 34 1: 33-41. 2000
• Komulainen M, Kröger H, Tuppurainen MT, Heikkinen A-M, Honkanen R, Saarikoski S. 2000. Identification of early postmenopausal women with no bone response to HRT; results of a 5-year clinical trial. OSTEOPOROSIS INTERNATIONAL 11: 211-218. 2000
• Heikkinen A-M, Niskanen L, Ryynänen M, Komulainen MH, Tuppurainen MT, Parviainen M, Saarikoski S. 1999. Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype? ARTERIOSCLEROSIS, THROMBOSIS AND VASCULAR BIOLOGY 19: 402-407. 1999
• Komulainen M, Kröger H, Tuppurainen MT, Heikkinen A-M, Alhava E, Honkanen R, Jurvelin J, Saarikoski S. 1999. Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 84: 546-552. 1999
• Tuppurainen MT, Komulainen M, Kröger H, Honkanen R, Jurvelin J, Puntila E, Heikkinen AM, Alhava E, Saarikoski S. 1998. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?. OSTEOPOROSIS INTERNATIONAL 7: 32-38. 1998
• Komulainen MH, Kröger H, Tuppurainen MT, Heikkinen A-M, Alhava E, Honkanen R, Saarikoski S. 1998. HRT and vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial. MATURITAS 31: 45-54. 1998
• Honkanen R, Tuppurainen M, Kröger H, Alhava E, Saarikoski S. 1998. Relationships between risk factors and fractures differ by type of fracture: a population-based study of 12192 perimenopausal women OSTEOPOROSIS INTERNATIONAL 8: 25-31. 1998
• Heikkinen A-M, Parviainen MT, Tuppurainen MT, Niskanen L, Komulainen MH, Saarikoski S. 1998. Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. CALCIFIED TISSUE INTERNATIONAL 62: 26-30. 1998
• Heikkinen A-M, Niskanen L, Ylä-Herttuala S, Luoma J, Tuppurainen MT, Komulainen M, Saarikoski S. 1998. Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL. MATURITAS 29: 155-161. 1998
• Heikkinen A-M, Parviainen M, Niskanen L, Komulainen M, Tuppurainen MT, Kröger H, Saarikoski S. 1997. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: A prospective, controlled, randomized stydy JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 82: 2476-2482. 1997
• Heikkinen A-M, Tuppurainen MT, Niskanen L, Komulainen M, Penttilä I, Saarikoski S. 1997. Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. EUROPEAN JOURNAL OF ENDOCRINOLOGY 137: 495-502. 1997
• Honkanen R, Kröger H, Alhava E, Turpeinen P, Tuppurainen M, Saarikoski S. 1997. Lactose intolerance associated with fractures of weight-bearing bones in finnish women aged 38-57 years. BONE 21 6: 473-477. 1997
• Honkanen R, Tuppurainen M, Kroger H, Alhava E, Puntila E. 1997. Associations of early premenopausal fractures with subsequent fractures vary by sites and mechanisms of fractures CALCIFIED TISSUE INTERNATIONAL 60: 327-331. 1997
• Komulainen M, Tuppurainen MT, Kröger H, Heikkinen AM, Puntila E, Alhava E, Honkanen R, Saarikoski S. 1997. Vitamin D and HRT: No benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled stydy. OSTEOPOROSIS INTERNATIONAL 7: 126-132. 1997
• Puntila E, Kröger H, Lakka T, Honkanen R, Tuppurainen M. 1997. Physical activity in adolescence and bone density in peri- and postmenopausal women: A population-based study BONE 21: 363-367. 1997
• Honkanen R, Pulkkinen P, Järvinen R, Kröger H, Lindstedt K, Tuppurainen M, Uusitupa M. 1996. Does lactose intolerance predispose to low bone density? A population-based study of perimenopausal Finnish women BONE 19 1: 23-28. 1996
• Honkanen R, Kröger H, Tuppurainen M, Alhava E, Saarikoski S. 1995. Fractures and low axial bone density in perimenopausal women JOURNAL OF CLINICAL EPIDEMIOLOGY 48 7: 881-888. 1995
• Kröger H, Huopio J, Honkanen R, Tuppurainen M, Puntila E, Alhava E, Saarikoski S. 1995. Prediction of fracture risk using axial bone mineral density in a perimenopausal population: a prospective study. JOURNAL OF BONE AND MINERAL RESEARCH 10 2: 302-306. 1995
• Tuppurainen M, Heikkinen A-M, Penttilä I, Saarikoski S. 1995. Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3. MATURITAS 22: 55-61. 1995
• Tuppurainen M, Kröger H, Honkanen R, Puntila E, Huopio J, Saarikoski S, Alhava E. 1995. Risks of perimenopausal fractures - a prospective population-based study. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA 74: 624-628. 1995
• Tuppurainen M, Kröger H, Saarikoski S, Honkanen R, Alhava E. 1995. The effect of gynecological risk factors on lumbar and femoral bone mineral density in peri- and postmenopausal women. MATURITAS 21: 137-145. 1995
• Tuppurainen M. 1995. Osteoporosis Risk Factors and Fractures Among Perimenopausal Women Women. Kuopion yliopiston julkaisuja D. Lääketiede. 1995
• Kröger H, Alhava E, Honkanen R, Tuppurainen M, Saarikoski S. 1994. The effect of fluoridated drinking water on axial bone mineral density - a population-based study. BONE AND MINERAL 27: 33-41. 1994
• Tuppurainen M, Kröger H, Saarikoski S, Honkanen R, Alhava E. 1994. The effect of previous oral contraceptive use on bone mineral density in perimenopausal women OSTEOPOROSIS INTERNATIONAL 4: 93-98. 1994